Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 30
Filtrer
1.
Environ Sci Pollut Res Int ; 30(31): 77006-77021, 2023 Jul.
Article de Anglais | MEDLINE | ID: mdl-37249764

RÉSUMÉ

This study aims to investigate the relationship between environmental rationality and economic activities that accelerate environmental indicators in Asia. In the ecosphere, the environment is a predator of human consumption. The continent Asia holding more than 60% of the world's population is vulnerable to environmental deployment. The purpose of the study is to find the link between economic growth, globalization, biocapacity, energy intensity, and renewable energy to the ecological footprint (EFP) in Asian countries for the period of 1990-2017. For empirics, the econometric techniques applied are panel OLS, fixed effects, random effects, fully modified-OLS, DOLS, and generalized methods of moments techniques. The results prove that by increasing the share of renewable energy in total energy consumption the environmental quality is improved. The Pedroni cointegration test shows a long-term relationship exists between globalization, economic growth, and the environment. The results of all techniques show the similar effectiveness of all used economic indicators in the model that disturbs the environment with different intensities in each test. The results of FM-OLS show that with a 1% increase in economic growth, globalization, biocapacity, and population density the ecological footprint increases by 0.55%, 0.08%, 0.06%, and 0.03%, respectively. However, renewable energy improves the environment by 0.04%. The Granger causality analysis revealed a bidirectional causality between ecological footprint and globalization and between EFP and energy intensity. This study recommends that Asian countries should make sustainable environmental policies to protect the environment from further damage.


Sujet(s)
Dioxyde de carbone , Développement économique , Humains , Dioxyde de carbone/analyse , Asie , Internationalité , Énergie renouvelable
2.
Front Public Health ; 10: 832711, 2022.
Article de Anglais | MEDLINE | ID: mdl-35692339

RÉSUMÉ

Small- and medium-sized enterprises (SMEs) play an important role in sustainable development not only for their significant contribution to China's economy but also for their large share of total discharged pollutants. Despite the widely acknowledged importance and benefits of environmental management accounting (EMA), the level of adoption and implementation of EMA practice is still weak within SMEs in many countries, especially in China. The current systematic review aims to identify the barriers affecting the Chinese SMEs for adopting EMA practices along with the critical success factors required for adopting EMA practices by SMEs and their top management for ensuring sustainable corporate environmental performance in China. The study is carried out following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. In total, 73 articles were found to be eligible to be included in the systematic review, which was published on EMA in small- and medium-sized enterprises in China. Our study aims to document barriers to the adoption of EMA among Chinese SMEs. The review concluded that strict legislation and the availability of flexible financing options for SMEs can promote the adoption of EMA by SMEs. The establishment of environmental reporting systems and auditing mechanisms can further increase the utilization of EMA by small and medium firms. Barriers to EMA adoption can be mitigated after careful consideration of the current situation in SMEs. Documentation of significant barriers may help to form supportive policies which ultimately add to the efforts toward climate change mitigation.


Sujet(s)
Conservation des ressources naturelles , Chine
6.
PLoS One ; 14(8): e0220956, 2019.
Article de Anglais | MEDLINE | ID: mdl-31393971

RÉSUMÉ

OBJECTIVE: Severe hypoglycemia (blood glucose < 50 mg/dl) in hospitalized patients with diabetes mellitus is associated with poor outcomes such as increased mortality and readmission rates. We study the effects of system based interventions in managing severe hypoglycemia and its impact on outcomes. RESEARCH DESIGN AND METHODS: We performed retrospective review of pre- and post- intervention study to quantify severe hypoglycemia in patients admitted in the general internal medicine wards with primary or secondary diagnosis of diabetes mellitus based on ICD-9 and ICD-10 codes. We implemented multidisciplinary interventions including standardization of treatment, education of in-patient medical teams and physician notification and feedback immediately after severe hypoglycemia. The endpoints were the comparative analysis of incidence of severe hypoglycemia, in-patient mortality rate, 30-day mortality rate, 30-day readmission rate, recovery time from hypoglycemia, time to next glucose measurements, use of standardized treatment and physician notification rate pre-and post-intervention. RESULTS: The incidence of severe hypoglycemia per patient with diabetes was reduced from 9.6% (233/2416) to 5.6% (202/3607) (p<0.001) post-intervention. The in-patient mortality rate in patients with severe hypoglycemia reduced from 4.1% to 0% (p = 0.019), 30-day mortality rate reduced from 9.8% to 3.8% (p = 0.058) post-intervention. 30-day readmission rate was comparable between pre-intervention (31.7%) and post-intervention (29%) (p = 0.60). In comparison, the mortality and readmission rates of all diabetic patients did not reduce during the same observation periods. Recovery time reduced from 116 (83-161) to 75 (57-102) min (p<0.01), time to next glucose measurement reduced from 39.5 (34-48) to 32 (28-35) min (p<0.01), use of standardized treatment improved from 22.7% (53/233) to 72.2% (146/202) (p<0.001) and physician notification rate increased from 29.2 (68/233) to 84.7% (171/202) post-intervention. CONCLUSIONS: Our study shows that multidisciplinary strategies improves the process of early detection and management of severe hypoglycemia and reduce incidence and in-patient mortality rate.


Sujet(s)
Diabète/épidémiologie , Mortalité hospitalière , Hospitalisation/statistiques et données numériques , Hôpitaux communautaires , Hypoglycémie/épidémiologie , Hypoglycémie/thérapie , Patients hospitalisés/statistiques et données numériques , Équipe soignante , Sujet âgé , Femelle , Humains , Hypoglycémie/complications , Mâle
7.
Eur J Nucl Med Mol Imaging ; 46(6): 1226-1239, 2019 Jun.
Article de Anglais | MEDLINE | ID: mdl-30806750

RÉSUMÉ

PURPOSE: Revascularization aims to improve myocardial perfusion. However, changes in regional artery-specific quantitative perfusion after revascularization have not been systematically investigated. It is unclear whether artery-specific thresholds for coronary flow capacity (CFC) and/or relative perfusion predict improved stress perfusion after revascularization. We sought to determine the impact of revascularization based on predefined, artery-specific, severity size thresholds for CFC and/or relative perfusion defects. METHODS: Fifty patients underwent PET imaging before revascularization and then prospectively within 90 days after revascularization. Changes in regional myocardial blood flow (MBF) were stratified based on baseline perfusion abnormalities, baseline reduced CFC, and whether revascularization was performed in that region. RESULTS: Following angiographic stenosis-directed revascularization, in regions with relative perfusion abnormalities and decreased CFC, stress MBF (sMBF) increased by 0.51 cm3/min/g (59%) from baseline (p < 0.001). In regions without baseline perfusion abnormalities and yet decreased CFC, sMBF increased by 0.35 cm3/min/g (40%) from baseline (p < 0.001). In regions without perfusion abnormalities and normal CFC, sMBF did not increase significantly (+0.07 cm3/min/g, p = 0.56). Patients in whom revascularization was concordant with abnormal PET findings showed increased whole-heart sMBF (+0.22 cm3/min/g, p < 0.001), but in patients in whom revascularization was targeted only to regions without perfusion abnormalities or low CFC, sMBF did not change significantly (-0.06 cm3/min/g, p = 0.38). CONCLUSION: Revascularization targeted to regions with reduced CFC and relative perfusion abnormalities on baseline PET yielded significant improvements in sMBF. When revascularization was performed in regions without reduced CFC, sMBF did not improve.


Sujet(s)
Circulation coronarienne , Coeur/imagerie diagnostique , Imagerie de perfusion myocardique , Revascularisation myocardique , Tomographie par émission de positons , Adulte , Sujet âgé , Angiographie , Artères , Maladie des artères coronaires/imagerie diagnostique , Sténose coronarienne/imagerie diagnostique , Épreuve d'effort , Femelle , Humains , Traitement d'image par ordinateur , Mâle , Adulte d'âge moyen , Myocarde , Perfusion , Études prospectives , Enregistrements , Tomodensitométrie
8.
Curr Probl Cardiol ; 43(3): 68-110, 2018 Mar.
Article de Anglais | MEDLINE | ID: mdl-29471918

RÉSUMÉ

Diabetes mellitus (DM) has become a public health problem worldwide, and it has large implications for cardiovascular disease (CVD). In this article, we discuss the etiology and pathophysiology of CVD in DM including the effects of abnormal glucose homeostasis, genetic factors, epigenetics, apoptosis, common pathophysiological mechanisms shared by both DM and CVD, and contributions of other comorbidities. We then cover the pathogenesis of both atherosclerotic disease and cardiomyopathy in relation to DM. Finally, we discuss the prevention of heart disease in DM with a focus on hypertension and dyslipidemia management, weight loss, lifestyle changes, antiplatelet therapy, and glycemic control.


Sujet(s)
Diabète de type 2/complications , Cardiopathies , Hémodynamique/physiologie , Diabète de type 2/épidémiologie , Santé mondiale , Cardiopathies/épidémiologie , Cardiopathies/étiologie , Cardiopathies/prévention et contrôle , Humains , Prévalence , Facteurs de risque
9.
Curr Probl Cardiol ; 41(7-8): 235-244, 2016.
Article de Anglais | MEDLINE | ID: mdl-27908388

RÉSUMÉ

Patients with coronary artery disease (CAD) are destined to lifelong antiplatelet therapy in form of aspirin (acetylsalicylic acid) alone, or in combination with other P2Y2 inhibitors. Proton pump inhibitors (PPIs) are the preferred agents for the treatment and prophylaxis of gastrointestinal injury associated with nonsteroidal anti-inflammatory drug or acetylsalicylic acid or both,1 but recent data has raised questions about their association with negative cardiovascular events. We report 2 cases of patients with known CAD presented with chest pain mimicking angina pectoris that successfully resolved on discontinuation of the PPIs. One male and one female patient with known history of CAD receiving PPIs were referred to us with symptoms of refractory angina that was unresponsive to conventional optimized medical therapy. The angina was reported to be related to exertion in both the patients. Neither patient had a diagnosis of Prinzmetal angina or peptic ulcer disease; however, both patients reported a history of gastroesophageal reflux disease. Both patients were on dual antiplatelet therapy. No ischemic changes on the electrocardiogram were noted for either patient. Patient 1 had an exercise stress test that was negative for any inducible ischemia whereas patient 2 had no obstructive lesion seen on coronary angiography. Both patients reported to be symptom free after discontinuation of PPIs at 8 months of follow-up. It is our opinion that a relationship between PPIs and angina-like chest pain is plausible, as these 2 cases demonstrate the causative role of PPIs in precipitation of their symptoms. We postulate that this association should be considered in differential diagnosis of chest pain. In light of above findings we suggest that this is hypothesis generating and we are exploring the role of PPIs in patients with history of CAD and refractory angina-like symptoms despite complete revascularization.


Sujet(s)
Douleur thoracique/induit chimiquement , Maladie des artères coronaires/thérapie , Inhibiteurs de la pompe à protons/effets indésirables , Sujet âgé , Angine de poitrine/diagnostic , Douleur thoracique/diagnostic , Maladie des artères coronaires/complications , Diagnostic différentiel , Épreuve d'effort , Femelle , Humains , Mâle , Adulte d'âge moyen
10.
Neurohospitalist ; 6(2): 51-8, 2016 Apr.
Article de Anglais | MEDLINE | ID: mdl-27053981

RÉSUMÉ

BACKGROUND AND PURPOSE: With the "weekend effect" being well described, the Brain Attack Coalition released a set of "best practice" guidelines in 2005, with the goal to uniformly provide standard of care to patients with stroke. We attempted to define a "weekend effect" in outcomes among patients with intracranial hemorrhage (ICH) over the last decade, utilizing the Nationwide Inpatient Sample (NIS) data. We also attempted to analyze the trend of such an effect. MATERIALS AND METHODS: We determined the association of ICH weekend admissions with hospital outcomes including mortality, adverse discharge, length of stay, and cost compared to weekday admissions using multivariable logistic regression. We extracted our study cohort from the NIS, the largest all-payer data set in the United States. RESULTS: Of 485 329 ICH admissions from 2002 to 2011, 27.5% were weekend admissions. Overall, weekend admissions were associated with 11% higher odds of in-hospital mortality. When analyzed in 3-year groups, excess mortality of weekend admissions showed temporal decline. There was higher mortality with weekend admissions in nonteaching hospitals persisted (odds ratios 1.16, 1.13, and 1.09, respectively, for 3-year subgroups). Patients admitted during weekends were also 9% more likely to have an adverse discharge (odds ratio 1.09; 95% confidence interval: 1.07-1.11; P < .001) with no variation by hospital status. There was no effect of a weekend admission on either length of stay or cost of care. CONCLUSION: Nontraumatic ICH admissions on weekends have higher in-hospital mortality and adverse discharge. This demonstrates need for in-depth review for elucidating this discrepancy and stricter adherence to standard-of-care guidelines to ensure uniform care.

11.
J Cardiovasc Pharmacol Ther ; 20(6): 539-46, 2015 Nov.
Article de Anglais | MEDLINE | ID: mdl-25715308

RÉSUMÉ

OBJECTIVES: We sought to synthesize and analyze the available data from randomized controlled trials (RCTs) for trimetazidine (TMZ) in the prevention of contrast-induced nephropathy (CIN). BACKGROUND: Contrast-induced nephropathy after coronary angiography is associated with poor outcomes. Trimetazidine is an anti-ischemic drug that might reduce incidence of CIN, but current data are inconclusive. METHODS: We searched MEDLINE/PubMed, EMBASE, Scopus, Cochrane Library, Web of Science, and ScienceDirect electronic databases for RCTs comparing intravenous hydration with normal saline (NS) and/or N-acetyl cysteine (NAC) versus TMZ plus NS ± NAC for prevention of CIN. We used RevMan 5.2 for statistical analysis with the fixed effects model. RESULTS: Of the 808 studies, 3 RCTs met criteria with 290 patients in the TMZ plus NS ± NAC group and 292 patients in the NS ± NAC group. The mean age of patients was 59.5 years, and baseline serum creatinine ranged from 1.3 to 2 mg/dL. Trimetazidine significantly reduced the incidence of CIN by 11% (risk difference 0.11; 95% confidence interval, 0.16-0.06; P < .01). There was no significant heterogeneity between the studies (I(2) statistic = 0). The number needed to treat to prevent 1 episode of CIN was 9. CONCLUSIONS: The addition of TMZ to NS ± NAC significantly decreased the incidence of CIN in patients undergoing coronary angiography. In conclusion, TMZ could be considered as a potential tool for prevention of CIN in patients with renal dysfunction.


Sujet(s)
Produits de contraste/effets indésirables , Maladies du rein/induit chimiquement , Maladies du rein/prévention et contrôle , Insuffisance rénale chronique/complications , Trimétazidine/usage thérapeutique , Vasodilatateurs/usage thérapeutique , Sujet âgé , Femelle , Humains , Mâle , Adulte d'âge moyen , Essais contrôlés randomisés comme sujet
12.
Am J Hypertens ; 26(2): 287-97, 2013 Feb.
Article de Anglais | MEDLINE | ID: mdl-23382415

RÉSUMÉ

BACKGROUND: Dual calcium-channel blocker (CCB) with a dihydropyridine (DHP) and a nondihydropyridine (NDHP) has been proposed for hypertension treatment. However, the safety and efficacy of this approach is not well known. METHODS: A MEDLINE/EMBASE/CENTRAL search for randomized clinical trials published on this topic from 1966 to February 2012 was performed. Efficacy outcomes of decrease in systolic (SBP) and diastolic (DBP) blood pressures from baseline, changes in heart rate (HR), and adverse effects were compared between dual CCB therapy vs. DHP or NDHP. SBP, DBP, and HR were expressed as weighted mean deviation (WMD). RESULTS: A total of 6 studies with 153 patients were included. Dual CCB produced a significantly greater reduction in SBP (21.6±9.2 mmHg) from baseline than DHP (10.3±6.3 mmHg (WMD = 10.9 mmHg, P < 0.0001)) or NDHP (8.9±4.2 mmHg (WMD = 14.1 mmHg, P = 0.002)). Dual CCB therapy reduced DBP from baseline more than either monotherapy (dual CCB = 17.5±10.2 mmHg vs. DHP = 11.6±8.7 mmHg, WMD = 5.5 mmHg, P < 0.001; and NDHP = 10.5±5.6 mmHg, WMD = 5.3 mmHg, P = 0.03). Dual CCB therapy had significantly lower HR compared to DHP (P < 0.001) but was comparable to NDHP (P = 0.12) (Delta change dual CCB = -4.0±3.5 vs. DHP = -2.0±1.5 and NDHP = -6.0±5.0 beats/min). Dual CCB therapy did not increase adverse effects. CONCLUSIONS: Dual CCB therapy lowers blood pressure significantly better than CCB monotherapy, without an increase in adverse events. However, given the lack of long-term outcome data on efficacy and safety, dual CCB therapy should be used with restraint, if at all. Large-scale long-term trials are needed to further evaluate such a strategy.


Sujet(s)
Inhibiteurs des canaux calciques/effets indésirables , Inhibiteurs des canaux calciques/usage thérapeutique , Hypertension artérielle/traitement médicamenteux , Pression sanguine/effets des médicaments et des substances chimiques , Pression sanguine/physiologie , Inhibiteurs des canaux calciques/pharmacologie , Dihydropyridines/effets indésirables , Dihydropyridines/pharmacologie , Dihydropyridines/usage thérapeutique , Association de médicaments , Femelle , Humains , Hypertension artérielle/physiopathologie , Mâle , Adulte d'âge moyen , Essais contrôlés randomisés comme sujet , Résultat thérapeutique
13.
J Natl Med Assoc ; 104(3-4): 172-8, 2012.
Article de Anglais | MEDLINE | ID: mdl-22774384

RÉSUMÉ

BACKGROUND: Recent studies have shown that hypertension is inversely correlated with bone mineral density (BMD) as determined by dual energy x-ray absorptiometery (DXA) in different ethnic groups. But in most published studies, either the sample size was small or the study was limited by different measurement methods. These limitations leave this association controversial and inconclusive. The current study utilizes a sample of African American females referred for clinical screening of osteoporosis in our center to find out if any association of high blood pressure and BMD in this ethnic group exists. The secondary endpoint was to determine the effect of thiazide diuretics on BMD of the elderly African American females because, theoretically, thiazides are considered to have a positive impact on BMD. METHODS: In this retrospective, cross-sectional study, 10 years of data were reviewed from 1113 medical records of African American females aged 65 years and older whose BMD values were measured by DXA at the lumbar spine (L1-L4) and both femoral necks (the standard sites for BMD determination) along with their T scores and Z scores (used to determine osteopenia vs osteoporosis). Our exclusion criteria included patients who: (1) were current smokers, (2) had a previous oophorectomy, (3) had a history of corticosteroid use, (4) had a history of biphosphonate use, (5) were on hormone replacement therapy, and (6) were diabetic and taking either pioglitazones or roziglitazones. A total of 148 patients were excluded from the analysis due to either incomplete data or exclusion criteria. The remaining sample was then divided into 2 groups based on their hypertensive status. For the subanalysis, the hypertensive group was further divided into 2 additional groups based on their thiazide usage. RESULTS: We had complete data on 965 participants, of which 631 (65.3%) had a history of hypertension and 334 (34.7%) did not. Out of 631 hypertensive patients, 173 were found to be using thiazide diuretics as antihypertensive medication, while 458 were without thiazide diurectic use. The proportion of patients with both osteopenia and osteoporosis was similar in those with and without hypertension (50% vs 50%, p = .95 for osteopenia; 18% vs 19%, p = .95 for osteoporosis). There was no significant difference between the BMD at the lumbar spine, and right and left femoral necks between patients with and without hypertension. This lack of association held true when comparing the mean T scores and Z scores at the above sites. Within patients with a history of hypertension, there were no significant differences in the BMD, T score or Z score at any site with and without a history of thiazide diuretic use. CONCLUSION: Hypertension in elderly African American females aged at least 65 years was not found to be correlated with low BMD at either the lumbar spine (L1-L4) or both femoral necks when confounding factors were taken into consideration. Mean BMD of the hypertensive cohort taking thiazide diuretics was found lower at the lumbar spine as compared to the hypertensive patients not taking thiazide diuretics.


Sujet(s)
Hypertension artérielle/épidémiologie , Ostéoporose/épidémiologie , Sujet âgé , , Densité osseuse , Études transversales , Femelle , Humains , Hypertension artérielle/traitement médicamenteux , Études rétrospectives , Inhibiteurs du symport chlorure sodium/usage thérapeutique
14.
J Healthc Qual ; 34(4): 5-14, 2012.
Article de Anglais | MEDLINE | ID: mdl-22059781

RÉSUMÉ

We describe our experience with the Advanced Cardiac Admission Program (ACAP) at our institution. The ACAP program is a hospital-wide implementation of critical pathways-based management of all cardiac patients. Data review of patients admitted for acute coronary syndromes from the ACAP-PAIN database and a comparative study of outcomes before and after implementation of the pathways-based assessment and treatment protocols. In the pre-ACAP and post-ACAP patient groups, antiplatelet use at admission improved from 50% to 75% (p<.01), ACE-I use improved from 32% to 54% (p<.0001), statins use increased from 35% to 62% (p<.0001), and smoking cessation awareness increased from 15% to 86% (p<.0001). At 1-year follow-up, 84% of patients with CAD were treated with statins, and 47% had LDL cholesterol <100 mg/dL, compared with 20% and 9%, respectively, with conventional treatment before ACAP implementation (p<.0001). Recurrent angina symptoms and nonfatal myocardial infarction rates decreased from 28.5% to 13% (p = .02), and 15% to 5% (p = 0.03), respectively. Pathway-based programs like ACAP significantly enhance administration of guidelines-based cardioprotective medications both during hospital stay and at 1-year follow-up.


Sujet(s)
Syndrome coronarien aigu/traitement médicamenteux , Cardiotoniques/usage thérapeutique , Programme clinique/organisation et administration , Adhésion au traitement médicamenteux/statistiques et données numériques , Assurance de la qualité des soins de santé , Adulte , Sujet âgé , Femelle , Études de suivi , Humains , Mâle , Adulte d'âge moyen , Guides de bonnes pratiques cliniques comme sujet , Évaluation de programme , Résultat thérapeutique
15.
Heart Int ; 6(2): e12, 2011.
Article de Anglais | MEDLINE | ID: mdl-22049311

RÉSUMÉ

Hyperkalemia affects the myocardial tissue producing electrocardiographic abnormalities, such as prolongation of the P-R interval, tall peaked T waves, a reduction in the amplitude and an increase in the duration of P wave, and atrial and ventricular arrhythmias, including variable degree heart blocks. Elderly patients are particularly predisposed to developing hyperkalemia and the associated abnormalities due to an age-related reduction in glomerular filtration rate and pre-existing medical problems. Therefore, the impact of aging on potassium homeostasis must be taken into consideration, and preventive measures, such as early recognition of possible hyperkalemia in the geriatric population treated with certain medications or supplements must be investigated. The threshold for cardiac arrhythmias in the elderly can be lower than the general population. We report 3 unusual cases of mild hyperkalemia in elderly patients presenting with hypotension, syncope and variable degree heart blocks which resolved spontaneously with the correction of hyperkalemia.

16.
Heart Int ; 6(1): e2, 2011.
Article de Anglais | MEDLINE | ID: mdl-21977302

RÉSUMÉ

Malnutrition is common at hospital admission and tends to worsen during hospitalization. This controlled population study aimed to determine if serum albumin or moderate and severe nutritional depletion by Nutritional Risk Index (NRI) at hospital admission are associated with increased length of hospital stay (LOS) in patients admitted with acute decompensated heart failure (ADHF). Serum albumin levels and lymphocyte counts were retrospectively determined at hospital admission in 1740 consecutive patients admitted with primary and secondary diagnosis of ADHF. The Nutrition Risk Score (NRI) developed originally in AIDS and cancer populations was derived from the serum albumin concentration and the ratio of actual to usual weight, as follows: NRI = (1.519 × serum albumin, g/dL) + {41.7 × present weight (kg)/ideal body weight(kg)}. Patients were classified into four groups as no, mild, moderate or severe risk by NRI. Multiple logistic regressions were used to determine the association between nutritional risk category and LOS.Three hundred and eighty-one patients (34%) were at moderate or severe nutritional risk by NRI score. This cohort had lower BMI (24 ± 5.6 kg/m(2)), albumin (2.8±0.5 g/dL), mean NRI (73.5±9) and lower eGFR (50±33 mL/min per 1.73 m(2)). NRI for this cohort, adjusted for age, was associated with LOS of 10.1 days. Using the Multiple Logistic regression module, NRI was the strongest predictor for LOS (OR 1.7, 95% CI: 1.58-1.9; P=0.005), followed by TIMI Risk Score [TRS] (OR 1.33, 95% CI: 1.03-1.71; P=0.02) and the presence of coronary artery disease (OR 2.29, 95%CI: 1.03-5.1; P=0.04). Moderate and severe NRI score was associated with higher readmission and death rates as compared to the other two groups.Nutritional depletion as assessed by Nutritional Risk Index is associated with worse outcome in patients admitted with ADHF. Therefore; we recommend adding NRI to further risk stratify these patients.

17.
Case Rep Med ; 2011: 174132, 2011.
Article de Anglais | MEDLINE | ID: mdl-21961011

RÉSUMÉ

Aortic dissection is a potentially fatal but rare disease characterized by an aortic intimal tear with blood passing into the media creating a false lumen and with resultant high mortality depending on the location of dissection if not aggressively treated. Cocaine users are known to have a higher incidence of aortic dissection. We report here aortic dissection in a patient with cocaine abuse which did not respond to traditional medication regimes used currently in this setting. Worth mentioning is the use of an alpha-2 receptor selective agonist named Dexmedetomidine as a treatment modality to control hypertension in this patient, which is approved only for sedation of intubated and mechanically ventilated patients in the intensive care settings and for sedation during invasive procedures. This paper illustrates the practical beneficial role of Dexmedetomidine in controling blood pressure in the settings of cocaine-induced sympathetic surge when other treatment modalities fail.

18.
Crit Pathw Cardiol ; 10(1): 22-8, 2011 Mar.
Article de Anglais | MEDLINE | ID: mdl-21562371

RÉSUMÉ

There is robust evidence to support the concept that critical pathways, derived from evidence-based guidelines, are an effective strategy for bridging the gap between published guidelines and clinical practice. It was with this idea in mind that in 2004 we developed an innovative novel program at our institution, that is, the "Advanced Cardiac Admission Program." The Advanced Cardiac Admission program consists of tools and strategies for implementing American College of Cardiology or American Heart Association guidelines into daily clinical practice. The program is composed of 8 novel critical pathways for the management of cardiac patients. In this article, we describe our experience in successfully implementing this program at our institutions.


Sujet(s)
Service hospitalier de cardiologie , Programme clinique/organisation et administration , Mise en oeuvre des programmes de santé/organisation et administration , Cardiopathies/thérapie , Guides de bonnes pratiques cliniques comme sujet , Association américaine du coeur , Médecine factuelle , Adhésion aux directives , Humains , Gestion des soins aux patients , Évaluation de programme , Résultat thérapeutique , États-Unis
19.
Hosp Pract (1995) ; 39(1): 126-32, 2011 Feb.
Article de Anglais | MEDLINE | ID: mdl-21441767

RÉSUMÉ

BACKGROUND: Loop diuretics are considered first-line therapy for patients with acute decompensated heart failure (ADHF). Adding nitroglycerin (NTG) to diuretic therapy for alleviation of acute shortness of breath has been advocated in our institution. We evaluated the benefits of adding NTG to diuretics in the emergency department for patients with ADHF and chronic kidney disease (CKD). METHODS: 430 consecutive patients with ADHF who were admitted with a chief complaint of dyspnea were included in this retrospective study. Patients were divided into 3 groups. Group A patients were treated with neither diuretics nor NTG; Group B patients were treated with diuretics only; and Group C patients were treated with both diuretics and NTG. Estimated glomerular filtration rate (GFR) was calculated according to the Cockcroft-Gault formula. Follow-up was 36 ± 9 (mean ± standard deviation [SD]) months. Primary endpoints were readmission rate at 30 days and mortality at 24 months. RESULTS: 430 patients were included in this study (42% men; age, 69 ± 14 [mean ± SD] years); mean New York Heart Association class was 2.4 ± 0.7 (mean ± SD) and mean ejection fraction was 28% ± 17% (mean ± SD). Group A included 257 (59%) patients, Group B had 127 (29%) patients, and Group C had 46 (11%) patients. Group C patients were older (mean age, 72 ± 13 years) with lower body mass index (26 ± 7 kg/m2), lower estimated GFR (55.8 ± 38 mL/min per 1.73 m2), higher B-type natriuretic peptide levels (1112 ± 876 pg/mL; P = nonsignificant [NS]), and higher systolic and diastolic blood pressures on admission (P = 0.001). The primary endpoint was assessed as a composite of all-cause mortality and ADHF readmission seen in 143 (56%) Group A patients, 68 (53%) Group B patients, and 22 (48%) Group C patients (P = NS). At 30 days there were 53 (12%) readmissions--26 in Group A, 20 in Group B, and 7 in Group C (P = NS). However, survival at 24 months was higher in Group C (87%) compared with Groups A (79%) and B (82%) (P = 0.002). Using the Cox proportional-hazards regression module, early administration of NTG and Lasix (95% confidence interval [CI], 1.06-1.62; P = 0.01) followed by CKD stage (95% CI, 1.00-1.35; P = 0.04) were the only predictors for survival. CONCLUSION: There is a role for early administration of NTG in addition to diuretic therapy in patients admitted to the emergency department with ADHF, with resultant decreased length of stay and a trend toward a decrease in the composite endpoint of all-cause mortality and ADHF readmission. The mortality benefit at 2 years reported in our study is thought-provoking and raises a premise to be proven in randomized clinical trials.


Sujet(s)
Furosémide/usage thérapeutique , Défaillance cardiaque/traitement médicamenteux , Nitroglycérine/usage thérapeutique , Insuffisance rénale chronique/traitement médicamenteux , Inhibiteurs du symport chlorure potassium sodium/usage thérapeutique , Vasodilatateurs/usage thérapeutique , Sujet âgé , Loi du khi-deux , Études transversales , Service hospitalier d'urgences , Femelle , Débit de filtration glomérulaire , Défaillance cardiaque/complications , Défaillance cardiaque/mortalité , Humains , Durée du séjour/statistiques et données numériques , Mâle , Réadmission du patient/statistiques et données numériques , Modèles des risques proportionnels , Insuffisance rénale chronique/complications , Insuffisance rénale chronique/mortalité , Études rétrospectives
20.
Respir Care ; 56(5): 691-4, 2011 May.
Article de Anglais | MEDLINE | ID: mdl-21276285

RÉSUMÉ

Bochdalek hernia occurs from a congenital defect of the diaphragm, allowing the passage of abdominal structures into the thoracic cavity, limiting lung expansion and ventilatory function. Bochdalek hernia is common in neonates but rarely occur in adults; there are only 4 documented cases in the elderly population. We present a case of an 88-year-old woman with severe hypoxia and respiratory failure that required ventilatory support, in whom bilateral Bochdalek hernias progressed over the years and severely invaded the thoracic cavity, causing acute decompensation. This is a rare condition in adults but can cause substantial morbidity when the involvement of the thoracic cavity is severe.


Sujet(s)
Insuffisance respiratoire/étiologie , Sujet âgé de 80 ans ou plus , Diagnostic différentiel , Femelle , Hernie diaphragmatique/complications , Hernie diaphragmatique/diagnostic , Hernies diaphragmatiques congénitales , Humains , Insuffisance respiratoire/diagnostic , Tomodensitométrie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...